Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012

被引:20
|
作者
Edwards, Hellen McKinnon [1 ]
Noer, Mette Calundann [2 ]
Sperling, Cecilie Dyg [3 ]
Nguyen-Nielsen, Mary [4 ,5 ]
Lundvall, Lene [2 ]
Christensen, Ib Jarle [6 ]
Hogdall, Claus [2 ]
机构
[1] Univ Copenhagen, Dept Obstet & Gynaecol, Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[2] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark
[3] Danish Canc Soc, Documentat & Qual, Copenhagen, Denmark
[4] Aarhus Univ Hosp Skejby, Dept Urol, Aarhus, Denmark
[5] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark
[6] Univ Copenhagen, Herlev Hosp, Dept Pathol, Herlev, Denmark
关键词
CO-MORBIDITY; POPULATION; STAGE; REGISTRY; AGE;
D O I
10.1080/0284186X.2016.1182641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ovarian cancer has a high mortality rate, especially in Denmark where mortality rates have been reported higher than in adjacent countries with similar demographics. This study therefore examined recent survival and mortality among Danish ovarian cancer patients over an 18-year study period.Methods: This nationwide registry-based observational study used data from the Danish Gynecology Cancer Database, Danish Pathology Registry, and Danish National Patient Registry. All patients with ovarian cancer diagnosed between 1995 and 2012 were included in the study. The data sources were linked via the patients' personal identification number and the analyses included data on cancer stage, age, survival, surgery status and comorbidity. The computed outcome measures were age-adjusted mortality rates and age-adjusted overall and relative survival rates for one and five years.Results: We identified 9972 patients diagnosed with ovarian cancer in the period 1995-2012. The absolute one-year mortality rate decreased from 42.8 (CI 40.3-45.6) in 1995-1999 to 28.3 (CI 25.9-30.9) in 2010-2012, and the five-year mortality rate decreased from 28.2 (CI 27.0-29.5) in 1995-1999 to 23.9 (CI 22.9-25.0) in 2005-2009. After stratification by age, comorbidity and cancer stage, the decrease in one-year mortality was most substantial in the 65-74 year old age group 41.1 (CI 38.8-43.5) to 26.5 (CI 24.4-28.7) and for stage III 39.1 (CI 35.1-43.6) to 22.9 (CI 19.9-26.5) and stage IV 91.3 (CI 80.8-103.2) to 41.9 (CI 35.5-49.5). For overall survival, we showed an increase in one-year survival from 68% (CI 66-69%) in 1995-1999 to 76% (CI 74-78%) in 2010-2012 and an increase in five-year survival from 33% (CI 32-35%) in 1995-1999 to 36% (CI 34-38%) in 2005-2009. Relative survival showed similar increases through the period.Conclusions: Ovarian cancer survival in Denmark has improved substantially from 1995 to 2012, bringing Denmark closer to the standards set by adjacent countries.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [31] K-ras alterations in Danish ovarian tumour patients.: From the Danish "Malova" ovarian cancer study
    Hogdall, EVS
    Hogdall, CK
    Blaakaer, J
    Christensen, L
    Bock, JE
    Vuust, J
    Glud, E
    Kjaer, SK
    GYNECOLOGIC ONCOLOGY, 2003, 89 (01) : 31 - 36
  • [32] Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study
    Heeran, Mel C.
    Hogdall, Claus K.
    Kjaer, Susanne K.
    Christensen, Lise
    Blaakaer, Jan
    Christensen, Ib Jarle
    Hogdall, Estrid V. S.
    APMIS, 2012, 120 (10) : 846 - 854
  • [33] Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group
    Lyhne, Nina Munk
    Johansen, Jorgen
    Kristensen, Claus Andrup
    Andersen, Elo
    Primdahl, Hanne
    Andersen, Lisbeth Juhler
    Oksbjerg, Susanne
    Overgaard, Jens
    EUROPEAN JOURNAL OF CANCER, 2016, 59 : 46 - 56
  • [34] Use of PARPi among patients with advanced ovarian cancer: Results from a real-world database
    Dawood, S.
    Brzozowski, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S740 - S741
  • [35] Therapy of Ovarian Cancer (OC) in Germany - Treatment characteristics and Survival Results of the QS OVAR 2012
    Harter, P.
    du Bois, A.
    Hilpert, F.
    Rochon, J.
    Lamparter, C.
    Kerkmann, M.
    Pfisterer, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 85 - 85
  • [36] The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study
    Ortoft, Gitte
    Hogdall, Claus
    Juhl, Caroline
    Petersen, Lone K.
    Hansen, Estrid S.
    Dueholm, Margit
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 68 - 76
  • [37] Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database
    Correa, Andres F.
    Handorf, Elizabeth
    Joshi, Shreyas S.
    Geynisman, Daniel M.
    Kutikov, Alexander
    Chen, David Y.
    Uzzo, Robert G.
    Viterbo, Rosalia
    Greenberg, Richard E.
    Smaldone, Marc C.
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1238 - 1244
  • [38] Re: Differences in Survival Associated with Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database
    Aziz, Atiqullah
    May, Matthias
    Hakenberg, Oliver W.
    Brookman-May, Sabine D.
    EUROPEAN UROLOGY, 2018, 74 (05) : 678 - 679
  • [39] The Impact of Comorbidity on Survival of Danish Colorectal Cancer Patients from 1995 to 2006-A Population-Based Cohort Study
    Iversen, Lene H.
    NLrgaard, Mette
    Jacobsen, Jacob
    Laurberg, Soren
    SLrensen, Henrik T.
    DISEASES OF THE COLON & RECTUM, 2009, 52 (01) : 71 - 78
  • [40] Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer-Results of a Clinical Cancer Registry Database Analysis in Germany
    Armbrust, Robert
    Ledwon, Peter
    Von Rusten, Anne
    Schneider, Constanze
    Sehouli, Jalid
    CANCERS, 2022, 14 (19)